Sunrest Lifescience, a healthcare and personal care products manufacturer, launched an Initial Public Offering (IPO) on Monday, November 7. The IPO, valued at ₹10.9 crore (INR10 crore = approx. USD1.2 million), will remain open for three trading days until Thursday, November 9. The offering features a fresh issuance of 12.9 lakh shares, each priced at ₹84.
The allotment process for the shares is slated to conclude by Tuesday, November 15. Successful bidders will receive their shares in their demat accounts by Thursday, November 17. Refunds for unsuccessful bidders will commence from Wednesday, November 16. Each lot of shares is priced at ₹1,34,400.
The shares are set to be listed on the National Stock Exchange's Small and Medium Enterprises (NSE SME) platform by Monday, November 20. The IPO is managed by Mark Corporate Advisors and Skyline Financial Services.
The funds raised from the IPO will be utilized towards working capital needs, general corporate expenses, and public issue costs. Sunrest Lifescience, incorporated in 2017, produces a variety of healthcare and personal care products, including over-the-counter (OTC) brands.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.